Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Eli Lilly & Co., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term borrowings and current maturities of long-term debt 1.42 5.67 4.49 6.50 2.74 7.18 2.58 10.79 3.88 1.21 0.01 3.03 3.68 4.51 2.89 3.15 3.24 3.72 0.01 0.02 1.34 3.01 7.90
Accounts payable 3.71 4.04 3.85 4.10 3.82 4.07 3.87 4.06 4.20 4.51 3.79 3.90 3.55 3.53 3.05 3.42 3.25 3.34 3.50 3.45 3.25 2.97 2.94
Employee compensation 1.71 1.29 1.25 2.66 2.25 1.63 1.32 2.58 2.13 1.58 1.39 2.14 2.07 1.78 1.48 1.96 1.74 1.58 1.39 2.14 1.81 1.61 1.38
Sales rebates and discounts 15.33 14.40 12.92 14.66 16.44 17.32 14.75 18.26 19.90 18.95 17.93 17.75 18.05 16.98 14.43 14.03 14.91 14.72 12.43 12.55 13.07 12.59 11.44
Dividends payable 0.00 1.33 0.00 1.71 0.00 1.63 0.00 1.83 0.00 1.85 0.00 2.06 0.00 1.87 0.00 1.81 0.00 1.61 0.00 1.65 0.00 0.00 0.00
Short-term income taxes payable 8.22 6.89 6.91 1.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current liabilities 4.54 5.03 4.22 5.00 7.38 5.91 6.57 5.13 7.88 6.40 7.00 5.75 5.63 4.53 6.68 6.46 5.25 6.60 7.68 6.96 7.78 8.39 7.02
Current liabilities 34.92% 38.66% 33.64% 36.05% 32.63% 37.73% 29.09% 42.64% 37.98% 34.51% 30.11% 34.63% 32.98% 33.19% 28.53% 30.84% 28.39% 31.57% 25.01% 26.77% 27.25% 28.57% 30.68%
Long-term debt, excluding current maturities 35.56 33.87 38.59 36.24 38.42 33.02 38.41 28.62 30.95 33.13 35.51 29.78 29.80 31.22 32.30 31.44 32.21 30.82 34.59 35.57 37.17 35.90 34.02
Long-term income taxes payable 5.48 5.63 6.01 5.16 5.13 4.86 6.55 6.01 5.99 6.08 7.23 7.50 7.67 7.56 8.48 8.03 7.82 7.82 8.36 8.23 7.72 8.05 8.81
Other noncurrent liabilities 3.29 3.66 4.03 4.42 4.88 5.41 5.78 5.75 5.56 5.95 5.90 6.32 8.13 9.63 10.53 10.93 15.07 15.85 16.88 16.94 16.49 17.31 18.71
Noncurrent liabilities 44.32% 43.16% 48.63% 45.82% 48.42% 43.29% 50.74% 40.39% 42.49% 45.15% 48.64% 43.60% 45.60% 48.41% 51.30% 50.40% 55.10% 54.49% 59.83% 60.74% 61.38% 61.25% 61.54%
Total liabilities 79.25% 81.82% 82.27% 81.87% 81.06% 81.03% 79.83% 83.03% 80.48% 79.66% 78.75% 78.23% 78.58% 81.60% 79.83% 81.24% 83.49% 86.06% 84.84% 87.51% 88.63% 89.82% 92.22%
Common stock 0.51 0.59 0.66 0.75 0.79 0.83 0.93 0.93 1.02 1.08 1.12 1.20 1.25 1.26 1.27 1.22 1.24 1.25 1.28 1.28 1.36 1.43 1.46
Additional paid-in capital 6.29 7.02 7.73 9.45 9.71 10.04 10.96 11.33 12.36 12.68 12.78 13.99 14.39 14.33 14.19 14.00 14.02 13.95 14.05 14.54 15.24 15.80 15.95
Retained earnings 19.36 17.22 16.89 17.21 18.02 18.33 19.63 16.11 17.80 18.92 20.01 20.29 21.08 18.18 19.97 18.36 20.00 17.84 19.60 16.79 16.28 15.77 14.30
Employee benefit trust -2.62 -2.99 -3.37 -3.83 -3.99 -4.19 -4.71 -4.71 -5.20 -5.50 -5.67 -6.09 -6.35 -6.40 -6.42 -6.17 -6.25 -6.30 -6.43 -6.46 -6.86 -7.18 -7.33
Accumulated other comprehensive loss -2.79 -3.68 -4.22 -5.49 -5.65 -6.09 -6.72 -6.76 -6.54 -6.91 -7.11 -7.77 -9.05 -9.11 -9.01 -8.90 -12.81 -13.15 -13.65 -13.93 -14.92 -15.92 -16.75
Cost of common stock in treasury -0.05 -0.05 -0.06 -0.06 -0.04 -0.05 -0.05 -0.07 -0.08 -0.08 -0.08 -0.10 -0.11 -0.11 -0.11 -0.11 -0.11 -0.11 -0.11 -0.12 -0.13 -0.13 -0.14
Total Eli Lilly and Company shareholders’ equity 20.70% 18.11% 17.64% 18.03% 18.83% 18.87% 20.04% 16.83% 19.37% 20.18% 21.05% 21.52% 21.22% 18.16% 19.89% 18.40% 16.10% 13.48% 14.73% 12.10% 10.98% 9.75% 7.49%
Noncontrolling interests 0.05 0.08 0.09 0.10 0.11 0.10 0.13 0.14 0.15 0.16 0.20 0.25 0.20 0.24 0.28 0.36 0.41 0.46 0.43 0.39 0.38 0.43 0.29
Total equity 20.75% 18.18% 17.73% 18.13% 18.94% 18.97% 20.17% 16.97% 19.52% 20.34% 21.25% 21.77% 21.42% 18.40% 20.17% 18.76% 16.51% 13.94% 15.16% 12.49% 11.37% 10.18% 7.78%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Short-term borrowings and current maturities of long-term debt
The proportion of short-term borrowings relative to total liabilities and equity fluctuates considerably over the periods. Early figures show a decline from 7.9% to below 1%, followed by intermittent rises and falls, reaching a peak of 10.79% in late 2023. Overall, this indicates some volatility in short-term debt management.
Accounts payable
Accounts payable as a percentage of total liabilities and equity remains relatively stable, oscillating modestly between approximately 2.9% and 4.5%. There is a slight upward drift starting from 2023, peaking around 4.5%, suggesting a marginal increase in trade payables or credit usage over time.
Employee compensation
Employee compensation exhibits a cyclical pattern with peaks typically reaching about 2.5-2.6% and troughs around 1.25%. The data indicates seasonal fluctuations but no sustained upward or downward trend across the years, reflecting consistent compensation expense relative to company size.
Sales rebates and discounts
There is a notable increasing trend in sales rebates and discounts, starting from approximately 11.4% and peaking near 19.9% in early 2023. Subsequent periods show a decline but still remain elevated compared to earlier years, indicating heightened rebate or discount activities affecting gross revenue net of these deductions.
Dividends payable
Dividends payable data is sporadic but shows values generally in the range of 1.3% to 2.1%. This suggests a consistent but modest proportion of liabilities related to upcoming dividend obligations.
Short-term income taxes payable
Short-term income tax liabilities appear only in later periods, showing a sharp increase peaking at 8.22% in December 2024. This sharp rise may indicate a significant tax liability or payment scheduling change in recent years.
Other current liabilities
Other current liabilities generally decrease over the periods, from around 7% to below 5% towards the later dates, indicating a reduction in miscellaneous current financial obligations.
Current liabilities
Current liabilities as a whole show some oscillation but an overall upward trend, rising from just under 31% to approximately 38% by late 2025. This growth reflects an increasing short-term obligation burden relative to total financing.
Long-term debt, excluding current maturities
Long-term debt proportions fluctuate but show a decreasing tendency from over 37% to values mostly in the 28-38% range. Notably, spikes occur near 38-39% in later years, suggesting periodic increases in long-term debt financing.
Long-term income taxes payable
This liability remains relatively stable, mostly fluctuating between 4.5% and 8.8%, with a slight downward trend observed in the most recent years. This may reflect tax strategy or changes in deferred tax obligations.
Other noncurrent liabilities
This category shows a clear declining trend, decreasing steadily from around 18.7% to just over 3% by late 2025, suggesting significant reductions in other long-term obligations.
Noncurrent liabilities
Noncurrent liabilities overall decline from approximately 61.5% to the low 40% range. This reflects a substantial reduction in the company’s long-term debt and other noncurrent obligations relative to total financing sources.
Total liabilities
Total liabilities decrease from over 92% to just under 80%, indicating a gradual improvement in the company's leverage ratio with a higher share of equity in the capital structure over time.
Common stock
The share of common stock in total financing declines steadily from about 1.46% to roughly 0.5%, suggesting that the book value of common stock relative to total liabilities and equity is decreasing or that other equity components are growing relatively faster.
Additional paid-in capital
This equity component decreases significantly from nearly 16% to around 6%, indicating possible share repurchases, amortization of share premiums, or reclassifications impacting this account's size relative to total financing.
Retained earnings
Retained earnings show fluctuations, peaking at approximately 21% and declining to 16-17% in some periods, then rising again near 19%. This volatility suggests varying levels of retained profits and distributions over time.
Employee benefit trust
The negative balance related to the employee benefit trust reduces in magnitude from about -7.3% to roughly -2.6%, indicating improvements in this liability or asset account that favorably impact shareholders' equity.
Accumulated other comprehensive loss
This loss shows a consistent reduction in absolute value, improving from approximately -16.75% to near -2.8%, reflecting a decrease in accumulated unrealized losses or valuation adjustments.
Cost of common stock in treasury
This relatively minor negative equity component remains fairly constant around -0.1%, indicating stable treasury stock levels relative to total financing.
Total shareholders’ equity
Total equity rises from under 8% to above 20%, signaling a strengthened equity base relative to total liabilities and equity, consistent with a reduction in leverage and improved financial stability.
Noncontrolling interests
Noncontrolling interests decrease from about 0.4% to under 0.1%, implying reduced ownership by minority shareholders or consolidation effects.
Total liabilities and equity
By definition, this remains constant at 100% throughout all periods, serving as the baseline for all ratio calculations.